Moses Jennifer K.
CFO at G1 Therapeutics, Inc.
- Sold, on record
- $378k
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jan 5, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.UnusualJul 5, 2018 2018
Sold 750 shares at $45.66 ($34k)
Moses Jennifer K., VP of Finance & Admin
Sold 100% of holdings ($34k position)0 shares left1x usual sizeFiling
- 2 Form 4 sale G1 Therapeutics, Inc.UnusualAug 6, 2018 +32 days
Sold 750 shares at $50.79 ($38k)
Moses Jennifer K., VP of Finance & Admin
Sold 100% of holdings ($38k position)0 shares left1x usual sizeFiling
- 3 Form 4 sale G1 Therapeutics, Inc.UnusualSep 5, 2018 +30 days
Sold 750 shares at $59.60 ($45k)
Moses Jennifer K., VP of Finance & Admin
Sold 100% of holdings ($45k position)0 shares left1x usual sizeFiling
- 4 Form 4 sale G1 Therapeutics, Inc.UnusualOct 8, 2018 +33 days
Sold 750 shares at $44.52 ($33k)
Moses Jennifer K., VP of Finance & Admin
Sold 27.3% of holdings ($122k position)2,000 shares left1x usual sizeFiling
- 5 Form 4 sale G1 Therapeutics, Inc.UnusualNov 5, 2018 +28 days
Sold 750 shares at $41.38 ($31k)
Moses Jennifer K., VP of Finance & Admin
Sold 27.3% of holdings ($114k position)2,000 shares left1x usual sizeFiling
- 6 Form 4 sale G1 Therapeutics, Inc.UnusualDec 6, 2018 +31 days
Sold 750 shares at $34.00 ($26k)
Moses Jennifer K., VP of Finance & Admin
Sold 27.3% of holdings ($94k position)2,000 shares left1x usual sizeFiling
- 7 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 5, 2022 +1126 days
Sold 1,445 shares at $10.61 ($15k)
Moses Jennifer K., CFO
Sold 3.9% of holdings ($393k position)35,555 shares leftFirst sale on recordFiling
- 8 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 5, 2023 +365 days
Sold 2,368 shares at $5.53 ($13k)
Moses Jennifer K., CFO
Sold 3.9% of holdings ($333k position)57,820 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Jan 5, 2023 | G1 Therapeutics, Inc. | CFO | Form 4 sale | 2,368 | $13k | 3.9% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 5, 2022 | G1 Therapeutics, Inc. | CFO | Form 4 sale | 1,445 | $15k | 3.9% | Plan not stated | SEC |
| Dec 6, 2018 | Dec 7, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $26k | 27.3% | Unusual | SEC |
| Nov 5, 2018 | Nov 7, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $31k | 27.3% | Unusual | SEC |
| Oct 8, 2018 | Oct 10, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $33k | 27.3% | Unusual | SEC |
| Sep 5, 2018 | Sep 6, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $45k | 100.0% | Unusual | SEC |
| Aug 6, 2018 | Aug 6, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $38k | 100.0% | Unusual | SEC |
| Jul 5, 2018 | Jul 5, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $34k | 100.0% | Unusual | SEC |
| Jun 5, 2018 | Jun 5, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $29k | 100.0% | Unusual | SEC |
| May 7, 2018 | May 7, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $34k | 100.0% | Unusual | SEC |
| Apr 5, 2018 | Apr 5, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $28k | 100.0% | Unusual | SEC |
| Mar 5, 2018 | Mar 6, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $20k | 100.0% | Unusual | SEC |
| Feb 5, 2018 | Feb 6, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $17k | 100.0% | Unusual | SEC |
| Jan 5, 2018 | Jan 8, 2018 | G1 Therapeutics, Inc. | VP of Finance & Admin | Form 4 sale | 750 | $15k | 100.0% | Unusual | SEC |